Pseudocholinesterase Deficiency - PowerPoint PPT Presentation

1 / 16
About This Presentation
Title:

Pseudocholinesterase Deficiency

Description:

Condition is recognized most often when respiratory paralysis persists for a ... Physiological States: Neonates, elderly, and pregnant women ... – PowerPoint PPT presentation

Number of Views:1819
Avg rating:3.0/5.0
Slides: 17
Provided by: lifebrid
Category:

less

Transcript and Presenter's Notes

Title: Pseudocholinesterase Deficiency


1
Pseudocholinesterase Deficiency
  • Doctor, the patient is not waking up and
  • can not breathe on their own
  • What to do and what to think about
  • Dorian Korz PGY-1

2
House of God
  • Rule 4 The patient is the one with the disease
  • Rule 8 They can always hurt you more
  • Rule 13 The delivery of good medical care is to
    do as much nothing as possible

3
Case Presentation
  • I.I. is a 47yo AA woman with a longstanding past
    hx of ventral hernia with progressive several
    week hx of abdominal pain and vomiting
  • PMHx obese PSHx c-sections Rxsnone
  • Allergies NKDA SHX married6 children
  • 10/6/08 Ventral hernia repair with mesh
    uncomplicated recovery
  • 10/30/08 Debridement of necrotic skin and sub
    cut. tissues with application of wound VAC 3
    hour recovery on vent support

4
Case Presentation
  • Medical and cardiac clearance prior to first
    surgery, elevated BP and HR (130-140s)
  • Fevers, tachycardia, elev. BP s/p first surgery
    with Neg cultures hyperthyroidism Dxed with
    benign thyroid nodule Bxed
  • Anemia and pre-alb 5.3 poor nutritional state

5
Pseudocholinesterase Deficiency
  • Background
  • Pseudocholinesterase deficiency is an inherited
    enzyme abnormality that results in abnormally
    slow metabolic degradation of exogenous choline
    ester drugs
  • Examples succinylcholine, mivacurium, procaine,
    and cocaine

6
  • Background
  • Condition is recognized most often when
    respiratory paralysis persists for a prolonged
    period of time following administration of
    succinylcholine
  • Mainstay of treatment in these cases is
    respiratory support until passive diffusion of
    succ. choline from myoneural junction permits
    function of skeletal muscle

7
Pathophysiology
  • Pseudocholinesterase is produced in the liver and
    found in plasma. It has no known physiologic
    function other than to hydrolyze exogenous
    choline esters
  • Normal individuals hydrolyze 90-95 of IV succ.
    choline before it reaches the neuromuscular
    junction. 5-10 acts as Ach receptor agonist at
    N-M junction causing prolonged depolarization of
    the postsynaptic junction of the motor-end plate

8
Pathophysiology
  • We see its succ. cholines effects as initial
    fasciculations of skeletal muscle.
  • Flaccid paralysis develops within 1 minute
  • Normal subjects, skeletal muscle function returns
    within 5 mins

9
Frequency
  • The incidence of homozygous deficiency in the
    general population is 13,200
  • Found most commonly in people of European descent
    and rare in Asians

10
Genetics
  • Gene that codes for the pseudocholinesterase
    enzyme is located on Chromo 3 E1 locus on the Q
    arm
  • 96 of the population is homozygous for the
    normal genotype designated EuEu
  • Point Mutations Ea dibucaine resistant and Ef
    fluoride resistant
  • Es frameshift silent variant

11
Other causes of Low enzyme activity
  • Physiological States Neonates, elderly, and
    pregnant women
  • Pathologic conditions Chronic infections,
    extensive burns, liver dz, malignancy,
    malnutrition, uremia, poisoning by
    organophosphates
  • RXs Contraceptives, cyclophosphamide,
    glucocorticoids, metoclopramide, esmolol among
    others

12
Tests Plasma Assay and PCR
  • Dibucaine inhibition of hydrolysis of benzyl
    choline lower the percent inhibition the less
    activity of enzyme there is. Normal is 80 EuEu
    mutant alleles 20 EaEa EuEa heterozygous in the
    middle
  • Fluoride similar to Dibucaine but normal is 60
    and mutant allele is 36 EfEf

13
Tests
  • Acholest test paper plasma drop to paper changes
    colorimetric rxn changes green to yellow the
    longer the change takes the less enz. activity
    there is
  • PCR The Danish Cholinesterase Research Unit in
    Copenhagen, Denmark accepts outside patient
    samples for evaluation (Dr. Jørgen Viby-Mogensen)

14
Table 1                                         
                                                  
                               
15
Treatment
  • Prophylactic transfusion of FFP, risk of
    iatrogenic infections
  • Mechanical ventilatory support until patient
    recovers
  • Administration of cholinesterase inhibitors, such
    as neostigmine, controversial and possibly short
    lived effects requiring re-intubation

16
Legal/Medical Pitfalls and Patient Education
  • Cocaine use sudden cardiac death
  • Patients should be tested and family alerted by
    the patient for the potential of anesthesia
    complications
  • If confirmed, pt. may wear medic-alert bracelet
  • Take an adequate history, monitor skeletal muscle
    paralysis by electrical stimulation
  • Monitor the patient and provide support
Write a Comment
User Comments (0)
About PowerShow.com